Alaunos Therapeutics (TCRT) Treasury Shares (2009 - 2023)
Alaunos Therapeutics' (TCRT) quarterly Treasury Shares came in at $437500.0 in Q3 2023, down 53.46% YoY from $940000.0 in Q3 2022, and down 33.43% on a QoQ basis from $657187.0 in Q2 2023.
Alaunos Therapeutics (TCRT) Treasury Shares (2009 - 2023) Analysis & Trends
Alaunos Therapeutics (TCRT) has 15 years of Treasury Shares data on file, last reported at $437500.0 in Q3 2023.
- Quarterly Treasury Shares fell 53.46% year-over-year to $437500.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $437500.0 (down 53.46% YoY) and the FY2022 annual result came in at $62604.0, down 21.65% from the prior year.
- Treasury Shares declined to $437500.0 in Q3 2023, from $657187.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $1.6 million in Q1 2019 to a low of $62604.0 in Q4 2022.
- A 5-year average of $1.0 million and a median of $1.1 million in 2021 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2019 — Treasury Shares soared 37.75% — and 2021, when it plunged 89.84%.
- Tracing TCRT's Treasury Shares over 5 years: stood at $939636.0 in 2019, then retreated by 16.32% to $786280.0 in 2020, then sank by 89.84% to $79905.0 in 2021, then decreased by 21.65% to $62604.0 in 2022, then jumped by 598.84% to $437500.0 in 2023.
- The last three Treasury Shares figures came in at $437500.0 (Q3 2023), $657187.0 (Q2 2023), and $898125.0 (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Alaunos Therapeutics | 4.28 Mn | 4.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 437,500.00 |
| Sep 30, 2023 | 437,500.00 |
| Jun 30, 2023 | 657,187.00 |
| Jun 30, 2023 | 657,187.00 |
| Mar 31, 2023 | 898,125.00 |
| Mar 31, 2023 | 898,125.00 |
| Dec 31, 2022 | 62,604.00 |
| Dec 31, 2022 | 62,604.00 |
| Sep 30, 2022 | 940,000.00 |
| Sep 30, 2022 | 940,000.00 |
| Jun 30, 2022 | 1.16 Mn |
| Jun 30, 2022 | 1.16 Mn |
| Mar 31, 2022 | 993,879.00 |
| Mar 31, 2022 | 993,879.00 |
| Dec 31, 2021 | 79,905.00 |
| Dec 31, 2021 | 79,905.00 |
| Sep 30, 2021 | 1.51 Mn |
| Sep 30, 2021 | 1.51 Mn |
| Jun 30, 2021 | 1.07 Mn |
| Jun 30, 2021 | 1.07 Mn |